Neuromelanin-sensitive MRI discovered as potential psychosis biomarker
NIH-funded study found that a type of magnetic resonance imaging, called neuromelanin-sensitive MRI (NM-MRI) is a potential biomarker for psychosis.
Neuromelanin-sensitive MRI signal was found...
Cannabis dispensaries associated with alternating neighbourhood crime
Researchers at the University of Colorado Denver, USA, found that cannabis dispensaries associated with rise, then decline in some neighbourhood crime.
Appearing in Justice Quarterly,...
Higher rates of miscarriage could be caused by oral antifungal drug
Published in CMAJ, new research has found that oral antifungal drug used to treat yeast infections is linked to higher rates of miscarriage.
A commonly...
Blockchain Technology in Healthcare Market value to reach millions by 2025
Blockchain Technology in Healthcare Market size is set to exceed $1,636.7 (~€1447.28) million by 2025; according to a new research study published by Global...
Discover how Mackrell Turner Garrett is supporting cannabis law
The Cannabis Law department at Mackrell Turner Garrett declared itself open for business and its new website is another step in its ongoing commitment...
Eye damage: can heavy smoking impair vision?
Researchers have taken a closer look into eye damage, by understanding the detrimental effects of what chronic smoking can have on spatial and colour...
Have researchers found a new approach to treating aggressive cancer?
Researchers at MD Anderson, USA, discovered some forms of aggressive cancer may respond to a combination of immunotherapy and DNA damage repair inhibitors.
According to...
Home flooring toxins found and children carry the evidence
Presented at the American Association for the Advancement of Science, researchers found children to carry evidence of harmful substances from furniture and home flooring...
Did you know drug combination could treat advanced kidney cancer?
According to researchers from Dana-Farber Cancer Institute, USA, a drug combination could potentially become the first-line treatment for patients with advanced kidney cancer.
Patients who...
Artificially sweetened beverages could cause stroke in post-menopausal women
Among post-menopausal women, drinking multiple artificially sweetened beverages daily was associated with an increase in the risk of having a stroke.
According to research published...
Cannabis-based medicine to be tested in Azheimer’s trial
Alzheimer’s Research UK is committing nearly £300,000 (~€341,000) for a landmark phase II clinical trial of Sativex®, a cannabis-based medicine licensed in the UK.
The...
Could human gut bacterium reveal possible connection to depression?
Researchers have established a correlation between depression and a group of neurotransmitter-producing bacteria found in human gut bacterium.
From the U.S. Department of Energy's (DOE)...
In depth: Canada’s landmark Cannabis Act
Health Europa examines how the Cannabis Act, which came into force in October 2018, will operate alongside Canada’s existing medical cannabis framework.
The Cannabis Act...
New research indicates that physiological age is better at predicting death
Published in the European Journal of Preventive Cardiology, research says predicting death does not necessarily come down to how old you are, it comes...
Medical cannabis legislation – do we need more rules and research?
The European Parliament is calling for an EU-wide policy for medical cannabis legislation and appropriately funded scientific research.
Multiple EU countries have legalised the medical...
Could advanced software reduce arrhythmia heart disease?
Potentially lethal conditions such as arrhythmia heart disease may become easier to identify thanks to innovative new software that measures electrical activity in the...
Human papilloma virus: shaming women could put off cancer screening
The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, and potentially deter them from getting cervical screening.
According to...
Facilitating easier access to medical cannabis in Switzerland
Access to medical cannabis in Switzerland is strictly limited, but, thanks to a recent proposal, more patients look set to benefit from this innovative...
Dementia Consortium welcomes £9.5 million dementia drug discovery collab
The Dementia Consortium welcomes Johnson & Johnson Innovation, Takeda and Evotec to join the unique £9.5 million (~€10.85m) charity-industry dementia drug discovery collaboration.
This second...
Which strategies are most likely to slow down Parkinson’s disease?
Experts explore which of the existing strategies to slow down or stop the processes of Parkinson’s disease are most likely to be successful over...